A61K 47/6809
Antibiotics
Official title: {Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin}
A61K47/6809 (Antibiotics) appears on 426 US grants and 711 published applications in this corpus.
Search patents in A61K- Granted patents
- 426
- Published applications
- 711
- Assignees
- 270
- Inventors
- 1,309
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 13 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 0 |
| 2002 | 4 | 7 |
| 2003 | 8 | 10 |
| 2004 | 2 | 18 |
| 2005 | 1 | 14 |
| 2006 | 6 | 15 |
| 2007 | 2 | 20 |
| 2008 | 4 | 12 |
| 2009 | 11 | 31 |
| 2010 | 9 | 17 |
| 2011 | 9 | 16 |
| 2012 | 8 | 15 |
| 2013 | 14 | 16 |
| 2014 | 14 | 32 |
| 2015 | 21 | 45 |
| 2016 | 33 | 44 |
| 2017 | 28 | 53 |
| 2018 | 31 | 48 |
| 2019 | 26 | 44 |
| 2020 | 29 | 33 |
| 2021 | 28 | 43 |
| 2022 | 14 | 29 |
| 2023 | 21 | 35 |
| 2024 | 20 | 43 |
| 2025 | 22 | 46 |
| 2026 | 8 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CD38 antibody drug conjugate15 Sep 2026US 12,734,209 B2Ogory, Inc.
- Stabilized trioxacarcin antibody drug conjugates and uses thereof1 Sep 2026US 12,721,904 B2President and Fellows of Harvard College
- PH-responsive lipidoid nanoparticles for intracellular mRNA delivery25 Aug 2026US 12,714,690 B2Trustees of Tufts College
- Anti-EGFR antibody-drug conjugate with a cyclic dinucleotide derivative14 Jul 2026US 12,678,512 B2Daiichi Sankyo Company, Limited
- Compounds for fast and efficient click release16 Jun 2026US 12,653,914 B2Tagworks Pharmaceuticals B.V.
- Anti-trop2 antibody-drug conjugates comprising pnu-159682 derivatives8 Oct 2026US 2026/0306652 A1Merck Sharp & Dohme Corp.
- Anti-HER2 Antibodies and Immunoconjugates1 Oct 2026US 2026/0297214 A1Genentech, Inc.
- Trogocytosis in cancer cells and methods for treating cancer related thereto17 Sep 2026US 2026/0274990 A1Arizona Board of Regents on Behalf of the University of Arizona
- Cthrc1 is a novel immune checkpoint molecule in colorectal cancer10 Sep 2026US 2026/0265355 A1MaineHealth
- Anti-ceacam5/6 dual-binding antibodies3 Sep 2026US 2026/0258125 A1Nona Biosciences (Suzhou) Co., Ltd.
Most cited
By later US patents
- Lysosomal enzyme-cleavable antitumor drug conjugates653US 6,214,345 B1Bristol-Myers Squibb Company · 2001
- Therapeutic inhibitor of vascular smooth muscle cells562US 5,733,925 ANeoRx Corporation · 1998
- Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates493US 5,714,586 AAmerican Cyanamid Company · 1998
- Therapeutic inhibitor of vascular smooth muscle cells438US 5,981,568 ANeoRx Corporation · 1999
- Conjugates of methyltrithio antitumor agents and intermediates for their synthesis437US 5,773,001 AAmerican Cyanamid Company · 1998